Extendicare Inc. (TSE:EXE - Get Free Report) announced a monthly dividend on Monday, June 30th, TickerTech Dividends reports. Investors of record on Tuesday, July 15th will be given a dividend of 0.042 per share on Tuesday, July 15th. This represents a $0.50 annualized dividend and a dividend yield of 3.64%. The ex-dividend date is Monday, June 30th.
Extendicare Stock Up 0.3%
Shares of TSE EXE traded up C$0.04 during mid-day trading on Friday, hitting C$13.85. 187,264 shares of the stock traded hands, compared to its average volume of 181,757. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62. Extendicare has a 52 week low of C$7.10 and a 52 week high of C$15.24. The company has a market cap of C$1.16 billion, a price-to-earnings ratio of 17.66 and a beta of 1.26. The stock has a fifty day moving average price of C$14.13 and a 200-day moving average price of C$12.44.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on EXE shares. BMO Capital Markets lifted their price target on Extendicare from C$13.50 to C$14.50 in a research report on Monday, May 12th. TD Securities boosted their target price on Extendicare from C$13.00 to C$15.00 and gave the stock a "hold" rating in a report on Thursday, May 22nd.
Get Our Latest Stock Analysis on EXE
Extendicare Company Profile
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
